Sharon Silbiger

3.2k total citations · 1 hit paper
33 papers, 2.6k citations indexed

About

Sharon Silbiger is a scholar working on Public Health, Environmental and Occupational Health, Nephrology and Molecular Biology. According to data from OpenAlex, Sharon Silbiger has authored 33 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 10 papers in Nephrology and 8 papers in Molecular Biology. Recurrent topics in Sharon Silbiger's work include Pregnancy and Medication Impact (7 papers), TGF-β signaling in diseases (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Sharon Silbiger is often cited by papers focused on Pregnancy and Medication Impact (7 papers), TGF-β signaling in diseases (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Sharon Silbiger collaborates with scholars based in United States, France and Denmark. Sharon Silbiger's co-authors include Joel Neugarten, Anjali Acharya, Jun Lei, Bertram L. Kasiske, Fuad N. Ziyadeh, Ralph L. Nachman, Adam S. Asch, Joseph Satriano, Detlef Schlöndorff and Qing Ding and has published in prestigious journals such as Journal of Biological Chemistry, Kidney International and The American Journal of Medicine.

In The Last Decade

Sharon Silbiger

33 papers receiving 2.6k citations

Hit Papers

Effect of Gender on the Progression of Nondiabetic Renal ... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Silbiger United States 24 893 627 510 437 396 33 2.6k
Marc R. Liliën Netherlands 27 845 0.9× 218 0.3× 308 0.6× 178 0.4× 231 0.6× 77 2.4k
Sol Epstein United States 35 588 0.7× 498 0.8× 904 1.8× 437 1.0× 377 1.0× 104 4.4k
Tomáš Seeman Czechia 26 897 1.0× 266 0.4× 742 1.5× 571 1.3× 431 1.1× 120 3.5k
Thomas J. Neuhaus Switzerland 30 964 1.1× 259 0.4× 1.4k 2.8× 422 1.0× 224 0.6× 107 3.5k
Graham Lipkin United Kingdom 20 433 0.5× 373 0.6× 1.2k 2.4× 279 0.6× 143 0.4× 44 2.6k
E. Jennifer Weil United States 25 708 0.8× 480 0.8× 340 0.7× 252 0.6× 163 0.4× 41 2.1k
Agneta Ekstrand Finland 27 801 0.9× 1.0k 1.7× 742 1.5× 310 0.7× 106 0.3× 56 3.5k
José R. Weisinger Venezuela 26 1.1k 1.2× 306 0.5× 359 0.7× 327 0.7× 168 0.4× 61 2.4k
W. Woloszczuk Austria 32 561 0.6× 470 0.7× 1.0k 2.0× 365 0.8× 80 0.2× 156 3.7k
Jonas Axelsson Sweden 31 2.0k 2.3× 415 0.7× 661 1.3× 241 0.6× 101 0.3× 60 4.2k

Countries citing papers authored by Sharon Silbiger

Since Specialization
Citations

This map shows the geographic impact of Sharon Silbiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Silbiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Silbiger more than expected).

Fields of papers citing papers by Sharon Silbiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Silbiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Silbiger. The network helps show where Sharon Silbiger may publish in the future.

Co-authorship network of co-authors of Sharon Silbiger

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Silbiger. A scholar is included among the top collaborators of Sharon Silbiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Silbiger. Sharon Silbiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melamed, Michal L., Terri Blackwell, Joel Neugarten, et al.. (2010). Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney International. 79(2). 241–249. 46 indexed citations
2.
Kane, Gregory C., et al.. (2009). The Modern Teaching Physician—Responsibilities and Challenges: An APDIM White Paper. The American Journal of Medicine. 122(7). 692–697. 6 indexed citations
3.
Silbiger, Sharon & Joel Neugarten. (2008). Gender and human chronic renal disease. Gender Medicine. 5. S3–S10. 165 indexed citations
4.
Lei, Jun, et al.. (2004). Estradiol reverses renal injury in Alb/TGF-β1 transgenic mice. Kidney International. 66(6). 2148–2154. 60 indexed citations
5.
Silbiger, Sharon & Joel Neugarten. (2003). The Role of Gender in the Progression of Renal Disease. Advances in Renal Replacement Therapy. 10(1). 3–14. 115 indexed citations
6.
Neugarten, Joel, Bertram L. Kasiske, Sharon Silbiger, & Jens Randel Nyengaard. (2002). Effects of Sex on Renal Structure. ˜The œNephron journals/Nephron journals. 90(2). 139–144. 59 indexed citations
7.
Lei, Jun, et al.. (2002). Estradiol reverses TGF-β1–induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney International. 62(6). 1989–1998. 61 indexed citations
8.
Silbiger, Sharon, et al.. (2001). Protein kinase CK2 mediates TGF-β;1-stimulated type IV collagen gene transcription and its reversal by estradiol1. Kidney International. 60(6). 2097–2108. 62 indexed citations
9.
Neugarten, Joel, Anjali Acharya, & Sharon Silbiger. (2000). Effect of Gender on the Progression of Nondiabetic Renal Disease. Journal of the American Society of Nephrology. 11(2). 319–329. 560 indexed citations breakdown →
10.
Neugarten, Joel, Anjali Acharya, Jun Lei, & Sharon Silbiger. (2000). Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. American Journal of Physiology-Renal Physiology. 279(2). F309–F318. 75 indexed citations
11.
Silbiger, Sharon, Jun Lei, & Joel Neugarten. (1999). Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. Kidney International. 55(4). 1268–1276. 61 indexed citations
12.
Neugarten, Joel, Gloria Gallo, Sharon Silbiger, & Bertram L. Kasiske. (1999). Glomerulosclerosis in aging humans is not influenced by gender. American Journal of Kidney Diseases. 34(5). 884–888. 65 indexed citations
13.
Silbiger, Sharon, et al.. (1997). Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. Kidney International. 51(5). 1535–1539. 22 indexed citations
14.
Neugarten, Joel, et al.. (1996). Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney International. 50(4). 1173–1179. 118 indexed citations
15.
Neugarten, Joel & Sharon Silbiger. (1995). Effects of sex hormones on mesangial cells. American Journal of Kidney Diseases. 26(1). 147–151. 46 indexed citations
16.
Silbiger, Sharon, et al.. (1995). Glomerular macrophages in nephrotoxic serum nephritis are activated to oxidize low-density lipoprotein. American Journal of Kidney Diseases. 26(2). 362–367. 5 indexed citations
17.
Fishbane, Steven, et al.. (1995). Hypervitaminosis A in two hemodialysis patients. American Journal of Kidney Diseases. 25(2). 346–349. 30 indexed citations
18.
Silbiger, Sharon & Joel Neugarten. (1995). The impact of gender on the progression of chronic renal disease. American Journal of Kidney Diseases. 25(4). 515–533. 336 indexed citations
19.
Tan, David Wei‐Min, et al.. (1994). Intracellular glutathione influences collagen generation by mesangial cells. Kidney International. 46(2). 388–395. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026